Home Featured Page 300

Featured

Latest

The Psychedelic News Feed: November 3 – 9, 2025

The Psychedelic News Feed: November 10 – 16, 2025

Beyond the Brain Reset: Óscar Soto on Mechanisms of Psychedelic Action

Ayahuasca Podcast: Joe Moore – Safe Access, Breathwork and Building a Psychedelic Informed World

In Aspen, a Bipartisan Strategy for Ibogaine Takes Shape as Advocates Confront the Limits of Traditional Rehab

COMPASS Pathways expands its Discovery Center through new collaborations with world-leading...

Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and...

Psychedelics Show Promise for Treating Dementia

Catching Up with the Psychedelic Entourage Effect: Part 3 – Field...

Insight into Ayahuasca’s Antidepressant Effects

New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate

‘Pharmacopeia’ Season Finale Features Cutting Edge Psychedelic Research

The Role of Oxytocin in MDMA’s Prosocial Effects

The Ancestral Healing Power of Ayahuasca

Pharmacological Testing in Psychedelic Research

1...299300301 302 Page 300 of 302

The Psychedelic News Feed: November 3 – 9, 2025

The Psychedelic News Feed: November 10 – 16, 2025

Beyond the Brain Reset: Óscar Soto on Mechanisms of Psychedelic Action

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The Psychedelic News Feed: November 3 – 9, 2025

The Psychedelic News Feed: November 10 – 16, 2025

Beyond the Brain Reset: Óscar Soto on Mechanisms of Psychedelic Action

Ayahuasca Podcast: Joe Moore – Safe Access, Breathwork and Building a Psychedelic Informed World

In Aspen, a Bipartisan Strategy for Ibogaine Takes Shape as Advocates Confront the Limits of Traditional Rehab

COMPASS Pathways expands its Discovery Center through new collaborations with world-leading...

Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and...

Psychedelics Show Promise for Treating Dementia

Catching Up with the Psychedelic Entourage Effect: Part 3 – Field...

Insight into Ayahuasca’s Antidepressant Effects

New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate

‘Pharmacopeia’ Season Finale Features Cutting Edge Psychedelic Research

The Role of Oxytocin in MDMA’s Prosocial Effects

The Ancestral Healing Power of Ayahuasca

Pharmacological Testing in Psychedelic Research

EDITOR PICKS

The Psychedelic News Feed: November 3 – 9, 2025

The Psychedelic News Feed: November 10 – 16, 2025

Beyond the Brain Reset: Óscar Soto on Mechanisms of Psychedelic Action

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY